Preface: Antibody therapies for cancer

Oncogene

Volumn 26, Issue 25, 2007, Pages 3592-3593

  Bonavida, B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIIDIOTYPIC ANTIBODY; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; EPRATUZUMAB; GEMTUZUMAB OZOGAMICIN; IBRITUMOMAB TIUXETAN; IRINOTECAN; MONOCLONAL ANTIBODY; PANITUMUMAB; RITUXIMAB; TOSITUMOMAB I 131; TRASTUZUMAB;

B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CLINICAL TRIAL; COLORECTAL CANCER; DRUG RESPONSE; DRUG TARGETING; EDITORIAL; HUMAN; IMMUNOPHARMACOLOGY; PASSIVE IMMUNIZATION; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, NEOPLASM; HUMANS; IMMUNOTHERAPY; NEOPLASMS;

EID: 34249752182     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210369     Document Type: Editorial

References (10)

1. Behring E. (1890). Uber das zustandekommen der diphterie-immunitat und der tetanus-immunitat bei theiren. Deut Med Wochenschr 14: 1113-1114.
2. Booy EP, Johar D, Maddika S, Pirzada H, Sahib MM, Gehrke I et al. (2006). Monoclonal and bispecific antibodies as novel therapeutics. Arch Immunol Ther Exp 54: 85-101.
3. Edelman GM, Gall WE, Waxdal MJ, Konigsberg WH. (1968). The covalent structure of a human gamma G-immunoglobulin. Part I. Isolation and characterization of the whole molecule, the polypeptide chains and the tryptic fragments. Biochemistry 7: 1950-1958.
4. Ehrlich P. (1900). On immunitywith special reference to cell life. Proc Roy Soc 66: 424-448.
5. Kohler G, Milstein C. (1975). Continuous cultures of fused cells secreting antibodyof predefined specificity. Nature 256: 495-497.
6. Miller RA, Maloney DG, Warnke R, Levy R. (1982). Treatment of B-cell lymphoma with monoclonal antiidiotypic antibody. N Engl J Med 306: 517-522.
7. Nadler LM, Stashenko P, Hardy R, Kaplan WD, Button LN, Kufe DW et al. (1980). Serotherapyof a patient with a monoclonal antibodydirected against a human lymphoma-associated antigen. Cancer Res 40: 3147-3154.
8. Porter RR. (1967). The structure of antibodies. The basic pattern of the principal class of molecules that neutralize antigens (foreign substances in the body) is four cross-linked chains. This pattern is modified so that antibodies can fit different antigens. Sci Am 217: 81-87.
9. Ritz J, Schlossman SF. (1982). Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma. Blood 59: 1-11.
10. Stern M, Herrmann R. (2005). Overview of monoclonal antibodies in cancer therapy: present and promise. Crit Rev Oncol Hematol 54: 11-29.